FR5021M - - Google Patents

Info

Publication number
FR5021M
FR5021M FR46254A FR46254A FR5021M FR 5021 M FR5021 M FR 5021M FR 46254 A FR46254 A FR 46254A FR 46254 A FR46254 A FR 46254A FR 5021 M FR5021 M FR 5021M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR46254A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5021M publication Critical patent/FR5021M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR46254A 1965-08-25 1966-01-18 Expired FR5021M (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3652065A GB1111433A (en) 1965-08-25 1965-08-25 A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions

Publications (1)

Publication Number Publication Date
FR5021M true FR5021M (ja) 1967-04-24

Family

ID=10388906

Family Applications (1)

Application Number Title Priority Date Filing Date
FR46254A Expired FR5021M (ja) 1965-08-25 1966-01-18

Country Status (3)

Country Link
BE (1) BE685950A (ja)
FR (1) FR5021M (ja)
GB (1) GB1111433A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311804D0 (en) * 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions

Also Published As

Publication number Publication date
GB1111433A (en) 1968-04-24
BE685950A (ja) 1967-02-01

Similar Documents

Publication Publication Date Title
JPS5011169B1 (ja)
JPS4424490Y1 (ja)
JPS451596Y1 (ja)
AU5791767A (ja)
BE660801A (ja)
BE661160A (ja)
BE661764A (ja)
BE663495A (ja)
BE663749A (ja)
BE663947A (ja)
BE666590A (ja)
BE667120A (ja)
BE667396A (ja)
BE667484A (ja)
BE667524A (ja)
BE668983A (ja)
BE669035A (ja)
BE669422A (ja)
BE669487A (ja)
BE669488A (ja)
BE671093A (ja)
BE672556A (ja)
BE672573A (ja)
BE672618A (ja)
BE672648A (ja)